Thomas Garite - 26 Aug 2021 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Reporting relationship: VP, Clinical Sciences
Issuer ticker: SERA
Reported as of: 26 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Sep 2021, 17:49:08 UTC
Prior SEC filing: 14 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Nishant Dharia, Attorney-in-fact

Key filing fact

Thomas Garite filed Form 4 for SERA PROGNOSTICS, INC. (SERA) on 09 Sep 2021.

Key facts

This page summarizes Thomas Garite's Form 4 filing for SERA PROGNOSTICS, INC. (SERA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Sep 2021, 17:49.

Change

Previous filing in this sequence was filed on 14 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SERA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 26 Aug 2021
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 10,000
Exercise price: $9.95
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/48th of the shares subject to this option will vest monthly beginning on September 26, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.